U.S., Sept. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07188402) titled 'Prevalence of Sleep Disturbances in Bullous Pemphigoid Patients.' on Sept. 17.
Brief Summary: Bullous pemphigoid (BP) is the most common autoimmune blistering disorder. The incidence of BP has increased due to increased life expectancy, particularly in developed countries, which can be associated with multiple geriatric comorbidities and polypharmacy.
Epidemiological studies of BP have shown that the incidence ranges from 2.5 to 42.8 cases/million/year in European countries.
BP affects older adults with multiple comorbidities, primarily neurological diseases such as multiple sclerosis, dementia, Parkinson's disease, epilepsy, and...